Biotech firms anticipate FDA approval, test results in 2008

12/31/2007 | Washington Post (tiered subscription model), The

Many biotech companies will face "make-or-break moments" related to trial results and product approvals in 2008, industry expert Edward M. Rudnic said. United Therapeutics Corp. and GenVec are expecting clinical trial results of their drug candidates for pulmonary hypertension and pancreatic cancer, respectively, and MiddleBrook Pharmaceuticals and Vanda Pharmaceuticals are expecting FDA decisions on drugs for amoxicillin and schizophrenia.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD